HISTORICAL FACTS: 5 | History Defined

Robinhood And 3 Other Stocks Insiders Are Selling

US crude oil futures traded higher this morning on Wednesday after dropping sharply in the previous session. Investors, meanwhile, focused on some notable insider trades.

Benzinga · Jul 13, 2022

Analyzing Centene's Short Interest

Centene's (NYSE:CNC) short percent of float has risen 55.64% since its last report. The company recently reported that it has 8.31 million shares sold short, which is 2.07% of all regular shares that are available for trading.

Benzinga · Jun 29, 2022

If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today

Centene (NYSE:CNC) has outperformed the market over the past 5 years by 6.23% on an annualized basis producing an average annual return of 16.19%. Currently, Centene has a market capitalization of $49.46 billion.

Benzinga · Jun 27, 2022

Britain’s biggest chain of GP surgeries accused of ‘profiteering’

BBC Panorama claims Operose Health uses physician associates, who are cheaper to employ than doctors, to assess patients

The Guardian - UK · Jun 13, 2022

Looking Into Centene's Recent Short Interest

Centene's (NYSE:CNC) short percent of float has risen 7.87% since its last report. The company recently reported that it has 7.85 million shares sold short, which is 1.37% of all regular shares that are available for trading.

Benzinga · Jun 13, 2022

Here's How Much $1000 Invested In Centene 5 Years Ago Would Be Worth Today

Centene (NYSE:CNC) has outperformed the market over the past 5 years by 5.11% on an annualized basis producing an average annual return of 14.96%. Currently, Centene has a market capitalization of $45.83 billion.

Benzinga · Jun 10, 2022

$1000 Invested In Centene 15 Years Ago Would Be Worth This Much

Centene (NYSE:CNC) has outperformed the market over the past 15 years by 12.83% on an annualized basis producing an average annual return of 19.78%. Currently, Centene has a market capitalization of $48.21 billion.

Benzinga · May 31, 2022

What 4 Analyst Ratings Have To Say About Centene

Over the past 3 months, 4 analysts have published their opinion on Centene (NYSE:CNC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga · May 27, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022

Upgrades

Benzinga · May 26, 2022

Centene Offloads Two Pharmacy Businesses For $2.8B

Centene Corporation (NYSE:CNC) has agreed to sell Magellan Rx to Prime Therapeutics LLC and PANTHERx Rare to a consortium of The Vistria Group, General Atlantic, and Nautic Partners.  Centene expects to receive approximately $2.8 billion in aggregate proceeds from the transactions. Magellan Rx is a comprehensive pharmacy solutions organization with specialty drug management, Medicaid administration, and comprehensive pharmacy…

Benzinga · May 5, 2022